| David M Huffman, MD | |
|
5616 Brainerd Rd, Suite 208, Chattanooga, TN 37411-5310 | |
| (423) 265-3561 | |
| (423) 265-1364 |
| Full Name | David M Huffman |
|---|---|
| Gender | Male |
| Speciality | Endocrinology |
| Experience | 42 Years |
| Location | 5616 Brainerd Rd, Chattanooga, Tennessee |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1811101256 | NPI | - | NPPES |
| 4077168 | Medicaid | TN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RE0101X | Internal Medicine - Endocrinology, Diabetes & Metabolism | TNMD19974 (Tennessee) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Erlanger Medical Center | Chattanooga, TN | Hospital |
| Memorial Healthcare System, Inc | Chattanooga, TN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| David M. Huffman, M.d.,p.c. | 2961672852 | 3 |
News Archive
The U.S. Food and Drug Administration today granted accelerated approval to Calquence (acalabrutinib) for the treatment of adults with mantle cell lymphoma who have received at least one prior therapy.
Targeted and individually adapted information to the parents of small children would reduce the risk of accidents involving children in the home. This is shown by new research from the Faculty of Health and Society at Malmö University in Sweden.
WellPoint's profits are up in the fourth quarter. Meanwhile, CEO Angela Braly says premiums would rise under the Democrats' plans to require insurers to cover all Americans.
UC San Diego Sulpizio Cardiovascular Center is now offering patients with atrial fibrillation the breakthrough benefits of heat energy, or radio frequency waves, to irreversibly alter heart tissue that triggers an abnormal heart rhythm or arrhythmia.
A study conducted by a collaborative team led by researchers from the University of Southern California (USC) may lead to better insight into the clinical outcome for some patients with a particularly aggressive type of brain cancer. The research may also provide a framework for development of targeted drug treatments.
› Verified 6 days ago
| Entity Name | David M. Huffman, M.d.,p.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629255807 PECOS PAC ID: 2961672852 Enrollment ID: O20110901000453 |
News Archive
The U.S. Food and Drug Administration today granted accelerated approval to Calquence (acalabrutinib) for the treatment of adults with mantle cell lymphoma who have received at least one prior therapy.
Targeted and individually adapted information to the parents of small children would reduce the risk of accidents involving children in the home. This is shown by new research from the Faculty of Health and Society at Malmö University in Sweden.
WellPoint's profits are up in the fourth quarter. Meanwhile, CEO Angela Braly says premiums would rise under the Democrats' plans to require insurers to cover all Americans.
UC San Diego Sulpizio Cardiovascular Center is now offering patients with atrial fibrillation the breakthrough benefits of heat energy, or radio frequency waves, to irreversibly alter heart tissue that triggers an abnormal heart rhythm or arrhythmia.
A study conducted by a collaborative team led by researchers from the University of Southern California (USC) may lead to better insight into the clinical outcome for some patients with a particularly aggressive type of brain cancer. The research may also provide a framework for development of targeted drug treatments.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| David M Huffman, MD 5616 Brainerd Rd, Suite 208, Chattanooga, TN 37411-5310 Ph: (423) 265-3561 | David M Huffman, MD 5616 Brainerd Rd, Suite 208, Chattanooga, TN 37411-5310 Ph: (423) 265-3561 |
News Archive
The U.S. Food and Drug Administration today granted accelerated approval to Calquence (acalabrutinib) for the treatment of adults with mantle cell lymphoma who have received at least one prior therapy.
Targeted and individually adapted information to the parents of small children would reduce the risk of accidents involving children in the home. This is shown by new research from the Faculty of Health and Society at Malmö University in Sweden.
WellPoint's profits are up in the fourth quarter. Meanwhile, CEO Angela Braly says premiums would rise under the Democrats' plans to require insurers to cover all Americans.
UC San Diego Sulpizio Cardiovascular Center is now offering patients with atrial fibrillation the breakthrough benefits of heat energy, or radio frequency waves, to irreversibly alter heart tissue that triggers an abnormal heart rhythm or arrhythmia.
A study conducted by a collaborative team led by researchers from the University of Southern California (USC) may lead to better insight into the clinical outcome for some patients with a particularly aggressive type of brain cancer. The research may also provide a framework for development of targeted drug treatments.
› Verified 6 days ago
Dr. Pamela Rani Sud, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 725 Glenwood Drive, Suite E-500, Chattanooga, TN 37404 Phone: 423-495-2635 Fax: 423-495-2638 | |
David Shved, D.O. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 975 E 3rd St, Chattanooga, TN 37403 Phone: 423-778-5179 Fax: 423-778-2108 | |
Megan J Coylewright, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 975 E 3rd St, Chattanooga, TN 37403 Phone: 423-778-8258 | |
Dr. Charles Robert Bosshardt, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 2515 Desales Ave Ste 206, Chattanooga, TN 37404 Phone: 423-698-8101 Fax: 423-698-3450 | |
Dr. Elise Helene Marshall, DO Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 605 Glenwood Dr Ste 300, Chattanooga, TN 37404 Phone: 423-495-2690 Fax: 423-495-2698 | |
Dr. Joshua Warner Hornsby, M.D. Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 979 E 3rd St Ste A-440, Chattanooga, TN 37403 Phone: 423-778-2867 Fax: 423-778-2866 | |
Dr. Donald Franklin Mackler, MD Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 721 Glenwood Dr, Ste. W552, Chattanooga, TN 37404 Phone: 423-629-6258 Fax: 423-629-9531 |